SynBioBeta Speaker
Omri Amirav Drory
General Partner
NFX Fund
YEAR
25
May 2025, SynBioBeta
Speaker
Omri Amirav Drory is a General Partner at the NFX Capital, with ~$1.4B under management across 5 funds. Omri if focused on leading seed investments for companies at the intersection of tech and bio.
SynBioBeta 2025 - Session Speaker
Risk, Resilience & Returns: New Frameworks for SynBio Investment
Bringing together leaders in synthetic biology and finance, this session scrutinizes new methods for balancing uncertainty, sustaining resilience, and optimizing returns in a field characterized by rapid innovation and protracted development timelines. Panelists will examine strategies for portfolio diversification across pivotal subfields—ranging from biomaterials to industrial fermentation—while highlighting the vital role of thorough scientific diligence and regulatory insight. By emphasizing the synergy between rigorous research and principled investment approaches, this discussion offers a timely examination of how careful planning can guide groundbreaking discoveries from the laboratory into sustained commercial success.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include
2026
Event Updates